Literature DB >> 25012169

Renal angiotensin-converting enzyme upregulation: a prerequisite for nitric oxide synthase inhibition-induced hypertension?

Lodi C W Roksnoer1, Ewout J Hoorn2, A H Jan Danser3.   

Abstract

Entities:  

Keywords:  ENaC; hypertension; kidney; renin angiotensin system

Mesh：

Substances：

Year:  2014        PMID： 25012169      PMCID： PMC4243362          DOI： 10.1681/ASN.2014060549

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

Review 1.  ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

Authors:  A H Jan Danser; Wendy W Batenburg; Anton H van den Meiracker; Sergei M Danilov
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

2.  Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.

Authors:  Mieke van den Heuvel; Wendy W Batenburg; Sjaam Jainandunsing; Ingrid M Garrelds; Jeanette M G van Gool; Richard A Feelders; Anton H van den Meiracker; A H Jan Danser
Journal:  J Hypertens       Date:  2011-11       Impact factor: 4.844

3.  Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice.

Authors:  Theodora Alexiou; Wee Ming Boon; Derek A Denton; Robert Di Nicolantonio; Lesley L Walker; Michael J McKinley; Duncan J Campbell
Journal:  J Hypertens       Date:  2005-05       Impact factor: 4.844

4.  Renal nerves, WNK4, glucocorticoids, and salt transport.

Authors:  David H Ellison; Virginia L Brooks
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

5.  Intrarenal angiotensin II: interstitial and cellular levels and site of production.

Authors:  J P van Kats; M A Schalekamp; P D Verdouw; D J Duncker; A H Danser
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

6.  Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.

Authors:  Taiji Matsusaka; Fumio Niimura; Ira Pastan; Ayumi Shintani; Akira Nishiyama; Iekuni Ichikawa
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

7.  The absence of intrarenal ACE protects against hypertension.

Authors:  Romer A Gonzalez-Villalobos; Tea Janjoulia; Nicholas K Fletcher; Jorge F Giani; Mien T X Nguyen; Anne D Riquier-Brison; Dale M Seth; Sebastien Fuchs; Dominique Eladari; Nicolas Picard; Sebastian Bachmann; Eric Delpire; Janos Peti-Peterdi; L Gabriel Navar; Kenneth E Bernstein; Alicia A McDonough
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

8.  Aliskiren accumulation in the kidney: no major role for binding to renin or prorenin.

Authors:  Sascha Lange; Christoph Fraune; Natalia Alenina; Michael Bader; A H Jan Danser; Anne-Roos Frenay; Harry van Goor; Rolf Stahl; Genevieve Nguyen; Edzard Schwedhelm; Ulrich Otto Wenzel
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

9.  Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition.

Authors:  Jorge F Giani; Tea Janjulia; Nikhil Kamat; Dale M Seth; Wendell-Lamar B Blackwell; Kandarp H Shah; Xiao Z Shen; Sebastien Fuchs; Eric Delpire; Jorge E Toblli; Kenneth E Bernstein; Alicia A McDonough; Romer A Gonzalez-Villalobos
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

10.  AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Minolfa C Prieto-Carrasquero; Yuri Ozawa; L Gabriel Navar
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.